$RLMD insider trading

Over the last 12 months, Relmada Therapeutics insiders reported 8 buys totaling $4.0M and no sales across SEC Form 4 filings.

$4.0M
8
4
0%
Side
$100K$1.0MJun '26JulAugSep
Shenouda Maged
TRAVERSA SERGIO
Ence Chuck
Kelly Paul Edward

All insider trades

Scroll the table sideways for price, value and marks.

Sep 10, 2026Shenouda Maged▲ Buy200,000$4.22$844K+25%
Sep 10, 2026TRAVERSA SERGIO▲ Buy200,000$4.14$828K+15.4%
Dec 15, 2025TRAVERSA SERGIO▲ Buy27,500$4.12$113K+2.2%
Dec 15, 2025Shenouda Maged▲ Buy11,665$4.12$48K+1.5%
Nov 5, 2025Ence Chuck▲ Buy136,000$2.2$299K+50.8%
Nov 5, 2025TRAVERSA SERGIO▲ Buy272,500$2.2$600K+27.2%
Nov 5, 2025Shenouda Maged▲ Buy500,000$2.2$1.1M+173.4%
Nov 5, 2025Kelly Paul Edward▲ Buy90,000$2.2$198K+21.8%
Aug 28, 2025TRAVERSA SERGIO▲ Buy265,976$0.67$178K+36.2%

Every $RLMD filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Relmada Therapeutics filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $RLMD feed.